Robbins LLP Encourages Neogen Investors with Significant Losses to Join Class Action Lawsuit

Robbins LLP Class Action Lawsuit for Neogen Investors

On August 12, 2025, Robbins LLP made an important announcement for investors in Neogen Corporation (NASDAQ: NEOG), reminding them of an ongoing class action lawsuit for those who acquired stocks between January 6, 2023, and June 3, 2025. Investors who believe they have suffered significant financial loss due to the misleading statements issued by Neogen can contact Robbins LLP for more information on how to participate in the class action and possibly recover their losses.

Understanding the Case Against Neogen

Neogen Corporation, known for its food safety products and services, faces serious allegations stemming from its questionable integration process with 3M Company. According to the complaint submitted as part of the class action, Neogen made a succession of false and misleading statements about the smoothness of their integration. In truth, the company engaged in serious misrepresentations regarding this process, which ultimately compromised its financial health.

One of the critical claims put forth was that Neogen's GAAP net income took a substantial hit in Q2 of 2025, largely due to a staggering $461 million non-cash goodwill impairment charge linked to the 3M acquisition. In addition to this financial setback, the company revised its revenue and EBITDA outlooks downward, sparking concern among investors regarding its future trajectory. As a result of this negative news, Neogen's stock price dropped 5% on January 10, 2025, finishing at $12.36 per share.

The dire situation escalated when, on April 9, 2025, Neogen disclosed that its quarterly revenue had declined by 3.4%, reaching $221 million. This decline was partly attributed to the ongoing integration troubles. The company’s outlook once again received a blow, leading to further reductions in its fiscal year revenue and EBITDA forecast. Adding to investor woes, the CEO announced plans to step down, which contributed to a significant decline in the company's share price—a staggering 28% drop occurred following this announcement.

The Situation Deteriorates

By June 4, 2025, Neogen provided additional alarming updates, indicating an expected EBITDA margin lowered to the high teens—a sharp decline from the previous quarter's 22%. Following this news, Neogen's shares fell even deeper, closing at $4.96—an overall decline from a peak of $23.84 per share on August 15, 2023. This considerable drop in valuation resulted in a staggering loss of over $4 billion in market capitalization.

Acting on Your Rights

If you are a shareholder who has been adversely affected by these developments, Robbins LLP invites you to consider serving as a lead plaintiff in the class action lawsuit against Neogen. The lead plaintiff acts on behalf of other investors and plays a crucial role in steering the litigation process. However, it is important to note that shareholders do not need to actively participate in the litigation to recover any potential losses.

All legal representation through Robbins LLP is provided on a contingency fee basis, meaning shareholders will not incur any costs unless the case yields positive results. Interested investors can reach out directly to Robbins LLP via phone or complete a form for more information.

About Robbins LLP

Established in 2002, Robbins LLP is a recognized leader in litigation related to shareholder rights. With a commitment to assisting shareholders in recovering their losses and advocating for corporate governance accountability, Robbins LLP is dedicated to ensuring that company executives face proper scrutiny for any wrongdoing.

For further updates, investors are encouraged to sign up for Stock Watch, a service offered by Robbins LLP that alerts shareholders about settlements in class action cases and any corporate misconduct news.

Conclusion

Navigating the stock market can be complex, especially in light of misleading corporate practices. If you believe you are among those who suffered losses from Neogen Corporation, it is vital to reach out to Robbins LLP and assess your options in this significant class action lawsuit.

For immediate assistance, contact attorney Aaron Dumas, Jr. or call (800) 350-6003.